Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-25-000217·Immunocore Holdings plc
Schedule 13G ownership disclosure
IMMUNOCORE HOLDINGS PLC
ADR · CUSIP: 45258D105
Event date: 2025-03-31
- Filing-level shares
- 7,051,818
- Percent of class
- 14.1%
- T. Rowe Price Investment Management, Inc.
Shares: 7,051,818 · Class: 14.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000217
- Form type
- SCHEDULE 13G/A
- Filer
- Immunocore Holdings plc
- CIK
- CIK 1671927
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership